MedPath

Health-related quality of life, disease burden and cognition in meningioma patients and their informal caregivers

Completed
Conditions
meningioma
Primary brain tumor
10029211
Registration Number
NL-OMON43957
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

Patients:
(1) Adult patients, must be over 18 years old;
(2) Patients with a histologically confirmed or suspected intracranial meningioma;
(3) The end of the primary anti-tumor treatment was at least 5 years prior to inclusion. ;Every participant will be asked if there is an informal caregiver available to participate as well. They are:
(1) Adults; over 18 years old;
(2) The spouse, family member, or close friend of the patient;
(3) They provide the majority of emotional and physical support to the patient.

Exclusion Criteria

Patients:
(1) Currently receiving anti-tumor treatment;
(2) Having received whole-brain radiation for a disease other than a confirmed or suspected intracranial meningioma;
(3) Diagnosed with neurofibromatosis type 2;
(4) Diagnosed with a neurodegenerative disease influencing their cognitive abilities;
(5) Incompetent and not having a legal representative to provide consent to study participation on their behalf;
(6) Insufficient understanding of the Dutch language;
(7) Not signed informed consent.;Informal caregivers:
(1) Insufficient understanding of the Dutch language;
(2) Diagnosed with a neurodegenerative disease influencing their cognitive abilities;
(3) The patient does not sign informed consent;
(4) No signed informed consent.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath